Characteristics and Mechanisms of a Sphingolipid-associated Childhood Asthma Endotype

Daniela Rago, Casper-Emil T Pedersen, Mengna Huang, Rachel S Kelly, Gözde Gürdeniz, Nicklas Brustad, Hanna Knihtil, Kathleen A Lee-Sarwar, Andréanne Morin, Morten A Rasmussen, Jakob Stokholm, Klaus Bønnelykke, Augusto A Litonjua, Craig E Wheelock, Scott T Weiss, Jessica Lasky-Su, Hans Bisgaard, Bo L Chawes

38 Citationer (Scopus)


Rationale: A link among sphingolipids, 17q21 genetic variants, and childhood asthma has been suggested, but the underlying mechanisms and characteristics of such an asthma endotype remain to be elucidated. Objectives: To study the sphingolipid-associated childhood asthma endotype using multiomic data. Methods: We used untargeted liquid chromatography-mass spectrometry plasma metabolomic profiles at the ages of 6 months and 6 years from more than 500 children in the COPSAC 2010 (Copenhagen Prospective Studies on Asthma in Childhood) birth cohort focusing on sphingolipids, and we integrated the 17q21 genotype and nasal gene expression of SPT (serine palmitoyl-CoA transferase) (i.e., the rate-limiting enzyme in de novo sphingolipid synthesis) in relation to asthma development and lung function traits from infancy until the age 6 years. Replication was sought in the independent VDAART (Vitamin D Antenatal Asthma Reduction Trial) cohort. Measurements and Main Results: Lower concentrations of ceramides and sphingomyelins at the age of 6 months were associated with an increased risk of developing asthma before age 3, which was also observed in VDAART. At the age of 6 years, lower concentrations of key phosphosphingolipids (e.g., sphinganine-1-phosphate) were associated with increased airway resistance. This relationship was dependent on the 17q21 genotype and nasal SPT gene expression, with significant interactions occurring between the genotype and the phosphosphingolipid concentrations and between the genotype and SPT expression, in which lower phosphosphingolipid concentrations and reduced SPT expression were associated with increasing numbers of at-risk alleles. However, the findings did not pass the false discovery rate threshold of <0.05. Conclusions: This exploratory study suggests the existence of a childhood asthma endotype with early onset and increased airway resistance that is characterized by reduced sphingolipid concentrations, which are associated with 17q21 genetic variants and expression of the SPT enzyme.

TidsskriftAmerican Journal of Respiratory and Critical Care Medicine
Udgave nummer7
Sider (fra-til)853-863
Antal sider11
StatusUdgivet - 1 apr. 2021


Dyk ned i forskningsemnerne om 'Characteristics and Mechanisms of a Sphingolipid-associated Childhood Asthma Endotype'. Sammen danner de et unikt fingeraftryk.